Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
PHASE2A Six-Week, Randomized, Double-Blind, Parallel Group Extension Study To Eva...
Location
University of California, Irvine
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
PHASE2An open-label, multi-center, 6-week, sequential cohort study designed to de...
Location
Dept. of Psychiatry, Sheba Medical Center
A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study
PHASE2This is a prospective, six-week, randomized, double blind, placebo-controll...
Location
Mary ann Knisevich